Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,243,043
  • Shares Outstanding, K 188,638
  • Annual Sales, $ 2,759 M
  • Annual Income, $ -1,029 M
  • EBIT $ -192 M
  • EBITDA $ 892 M
  • 60-Month Beta 0.95
  • Price/Sales 3.55
  • Price/Cash Flow 9.22
  • Price/Book 4.08

Options Overview Details

View History
  • Implied Volatility 63.24% ( -3.07%)
  • Historical Volatility 32.73%
  • IV Percentile 80%
  • IV Rank 63.15%
  • IV High 77.02% on 07/29/24
  • IV Low 39.63% on 05/20/25
  • Put/Call Vol Ratio 0.59
  • Today's Volume 551
  • Volume Avg (30-Day) 2,388
  • Put/Call OI Ratio 0.97
  • Today's Open Interest 47,563
  • Open Int (30-Day) 44,353

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.02
  • Number of Estimates 5
  • High Estimate 0.06
  • Low Estimate -0.13
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +77.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.09 +5.79%
on 06/25/25
57.40 -7.68%
on 06/27/25
-0.53 (-0.99%)
since 06/13/25
3-Month
40.80 +29.88%
on 04/21/25
58.68 -9.70%
on 05/28/25
+9.32 (+21.34%)
since 04/15/25
52-Week
39.97 +32.57%
on 04/08/25
72.83 -27.24%
on 11/05/24
+5.94 (+12.62%)
since 07/15/24

Most Recent Stories

More News
Tempus AI Raises 2025 Financial Outlook: What's Backing It?

Tempus AI TEM expects full-year 2025 revenues of $1.25 billion (up from the previous $1.24 billion guidance), which represents approximately 80% annual growth. The company also expects adjusted EBITDA...

EXAS : 52.99 (-2.41%)
EXEL : 44.06 (-3.33%)
TEM : 55.89 (-3.34%)
What's Fueling Tempus AI's Explosive Sales Growth?

Chicago-based Tempus AI, Inc. TEM is experiencing robust revenue growth, marked by record-setting financial performance. In the first quarter of 2025, the company reported a 75.4% year-over-year increase...

AZN : 70.32 (-1.98%)
EXAS : 52.99 (-2.41%)
EXEL : 44.06 (-3.33%)
TEM : 55.89 (-3.34%)
Hologic Climbs 13% in a Month: How Should You Play the Stock?

After lagging for months, Hologic HOLX has picked up momentum in recent weeks. Shares of the Marlborough, MA-based company have climbed 13.3% over the past month, higher than the industry and the broader...

HOLX : 63.26 (-2.10%)
EXAS : 52.99 (-2.41%)
BDX : 178.31 (+0.69%)
Stocks Settle Higher on Trade Optimism and US Labor Market Strength

The S&P 500 Index ($SPX ) (SPY ) Friday closed up +1.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.60%. June E-mini S&P futures...

AMAT : 199.29 (+1.11%)
UAL : 86.38 (-2.88%)
AAPL : 209.11 (+0.23%)
AVGO : 280.94 (+1.94%)
EXAS : 52.99 (-2.41%)
IRM : 97.26 (-0.76%)
BIDU : 93.30 (+8.65%)
TXN : 218.36 (-0.77%)
ABNB : 136.54 (-1.46%)
$IUXX : 22,884.59 (+0.13%)
DUOL : 378.31 (+0.50%)
ZNU25 : 110-115 (+0.07%)
Stocks Supported by Hopes of US-China Trade Talks and a Buoyant US Labor Market

The S&P 500 Index ($SPX ) (SPY ) today is up +1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.30%. June E-mini S&P futures (ESM25...

AMAT : 199.29 (+1.11%)
UAL : 86.38 (-2.88%)
AAPL : 209.11 (+0.23%)
AVGO : 280.94 (+1.94%)
EXAS : 52.99 (-2.41%)
IRM : 97.26 (-0.76%)
BIDU : 93.30 (+8.65%)
TXN : 218.36 (-0.77%)
ABNB : 136.54 (-1.46%)
$IUXX : 22,884.59 (+0.13%)
DUOL : 378.31 (+0.50%)
ZNU25 : 110-115 (+0.07%)
Stocks Climb on Possible US-China Trade Talks and a Resilient US Labor Market

The S&P 500 Index ($SPX ) (SPY ) today is up +1.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.15%. June E-mini S&P futures (ESM25...

AMAT : 199.29 (+1.11%)
UAL : 86.38 (-2.88%)
AAPL : 209.11 (+0.23%)
EXAS : 52.99 (-2.41%)
BIDU : 93.30 (+8.65%)
TXN : 218.36 (-0.77%)
ABNB : 136.54 (-1.46%)
$IUXX : 22,884.59 (+0.13%)
DUOL : 378.31 (+0.50%)
ZNU25 : 110-115 (+0.07%)
PDD : 105.06 (+2.59%)
ESU25 : 6,276.25 (-0.12%)
Exact Sciences: Q1 Earnings Snapshot

Exact Sciences: Q1 Earnings Snapshot

EXAS : 52.99 (-2.41%)
2 Reasons to Like EXAS (and 1 Not So Much)

2 Reasons to Like EXAS (and 1 Not So Much)

EXAS : 52.99 (-2.41%)
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

NTRA : 149.85 (-5.27%)
EXAS : 52.99 (-2.41%)
INCY : 68.25 (-2.47%)
REGN : 547.96 (-3.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and...

See More

Key Turning Points

3rd Resistance Point 56.40
2nd Resistance Point 55.62
1st Resistance Point 54.31
Last Price 52.99
1st Support Level 52.22
2nd Support Level 51.44
3rd Support Level 50.13

See More

52-Week High 72.83
Fibonacci 61.8% 60.28
Fibonacci 50% 56.40
Last Price 52.99
Fibonacci 38.2% 52.52
52-Week Low 39.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar